The average one-year price target for Alexander's (NYSE:ALX) has been revised to $183.60 / share. This is an increase of 16.13% from the prior estimate of $158.10 dated November 7, 2025. The price ...
Stifel lowered the firm’s price target on ALX Oncology (ALXO) to $1.50 from $3 and keeps a Hold rating on the shares. Following a R&D day and the company’s Q4 report, the firm updated its model for ...
First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s choice of ...
The average one-year price target for ALX Oncology Holdings (NasdaqGS:ALXO) has been revised to $3.06 / share. This is an increase of 12.50% from the prior estimate of $2.72 dated November 7, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback